The Effect of Maternal Thyroid Disorders (Hypothyroidism and Hyperthyroidism) During Pregnancy and Lactation on Skin Development in Wistar Rat Newborns

Document Type: Original Article

Authors

1 Azad University of Shahrud, Medical Sciences School, Shahrud, Iran

2 Ferdowsi University of Mashhad, Faculty of Basic Sciences, Mashhad, Iran

3 Mashhad University of Medical Sciences school, Mashhad, Iran

Abstract

 

Objective(s):
Previous studies have shown that thyroid hormones are necessary for normal development of many organs and because of the importance of skin as the largest and the most important organ in human body protection in spite of external environment, the study of thyroid hormones effects on skin development is considerable. In this survey we have tried to study the effects of maternal hypothyroidism on skin development in fetus during pregnancy and lactation by immunohistochemistry technique.
 
Materials and Methods:
Rats were divided into 4 groups, hypothyroids, hyperthyroids, hypothyroids are treated with levothyroxin and a control group. The rat mothers were exposed to PTU with 50 mg/lit dosage and levothyroxin with 1 mg/lit dosage and PTU and levothyroxin simultaneously and with the same dosage respectively in hypothyroid, hyperthyroid and treated hypothyroids with levothyroxin groups. After 14 days, blood sample was taken from mothers, and if thyroid hormones level had change well, mating was allowed. After pregnancy and delivery, 1th day dorsal skin (as the sample for pregnancy assay) and 10th day skin (as for lactation assay) was used for immunohystochemical and morphometric studies.
Results:
In this study it was observed that maternal hypothyroidism during pregnancy and lactation causes significant increase in laminin expression, in most areas of skin, and maternal hyperthyroidism during pregnancy and lactation causes significant decrease in laminin expression. Also significant decrease was observed in hair follicles number and epidermis thickness in hypothyroidism groups.
Conclusion:
This study showed maternal hypothyroidism causes significant decrease in epidermis thickness and hair follicles number and it causes less hair in fetus. Also maternal hypothyroidism causes large changes in laminin expression in different parts of skin. At the same time,maternal hyperthyroidism causes opposite results. In fact, thyroid hormones regulate laminin expression negatively which means increase in thyroid hormone level, decreases laminin expression. So changes in thyroid hormones level can influence skin development significantly.

Keywords


References

1.

Billoni N, Buan B, Gautier B, Gaillard O, Mahe YF, Bernhard BA. Thyroid hormone receptor b1 is expressed in the human hair follicle. Br J Dermatol 2000; 142:645–652.

2.

Safer J, Fraser L, Ray S, Holick M. Topical Triiodothyronine Stimulates Epidermal Proliferation,Dermal Thickening, and Hair Growth in Mice and Rats. Thyroid 2000; 11:356-364.

3.

Peltonen J, Larjava H, Jaakkola S, Gralnick H, Akiyama S, Yamada S, et al. Localization of integrin receptors for fibronectin, collagen, and laminin in human skin variable expression in basal and squamous cell carcinomas. J Clin Invest 2000; 84:1916-1923.

4.

Schmehl K, Florian S, Jacobasch G, Salomon A. Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa. Int J Colorect Dis 2000; 15:39–48.

5.

Bauza E, Dal Farra C, Portolan F, Domloge N. New Laminin Peptide for Innovative Skin Care Cosmetics. Cosmet Toiletries 2003; 3:111-120.

6.

Wedad Z, Solzei M, Manal B, Sobhi R, Zaki N. An immunohistochemical study of laminin in cutaneous and mucosal squamous cell carcinomas. J Egypt women dermatology society. 2007; 4:1-10.

7.

Jalali M, Nikravesh MR, Moeen AA, Mohammadi SH, et al. Maternal nexposure on collagen type IV pulmonary changes in, mouse offspring's. J Iran Anatomic Sci 2010; 8:139-147.

8.

Nikravesh MR, Moeen AA, Jalali M, Mohammadi S, et al. Maternal nicotine induces collagen type IV changes and its role on pulmonary bronchogenesis and alveolarization in mouse newborns. J Pharmaceutic Sci; 16:181-186.

Amerion M et al Thyroid Disorders on Skin Development

Iran J Basic Med Sci, Vol. 16, No. 5, May 2013

 

674

 

9.

Gong H, Ye W, Freddo TF, Hernandez MR. Hyaluronic acid in the normal and glaucomatous optic nerve. Exp Eye Res 1997; 64:587-595.

10.

Kimura-Kuroda J, Nagata IN, Negishi-Kato M,Kuroda Y. Thyroid hormone-dependent development of mouse cerebellar Purkinje cells in vitro. J Brain Res Dev Brain Res 2007; 137:55-65.

11.

Koibuchi N, Chin W. Thyroid hormone action and brain development. J Trends Endocrinol Metabol 2005; 11:123-128.

12.

Zoeller RT, Crofton KM. Thyroid hormone action in fetal brain development and potential for disruption by environmental chemicals. J Neurotoxicol 2000; 21:935-945.

13.

Bassett J, Swinhoe R, Chassande O, Samarut J. Thyroid Hormone Regulates Heparan Sulfate Proteoglycan Expression in the Growth Plate. J Endocrinol 2005; 147:295-305.

14.

Knipper M, Zinn C, Maier H, Praetorius M. Thyroid hormone deficiency before the onset of hearing causes irreversible damage to peripheral and central auditory systems. J Neurophysiol 2007; 83:3101-112.

15.

Quatresooz P, Thirion L, Piérard-Franchimont C, Piérard GE. Cutaneous manifestations of endocrine disorders. Rev Med Liège 2006; 61:104–108.

16.

Slominski A. Neuroendocrine sytem of the skin. J Dermatol 2005; 211: 199–208.

17.

Farwell A, Dubord-Tomasetti S. Thyroid hormone regulates the expression of laminin in the developing rat cerebellum. J Endocrinol 1999; 140:4221-4227.

18.

Kung A. Thyroid disease in pregnancy. Hong Kong Med J 1997; 3:388-390.

19.

Burrow G. Maternal and fetal thyroid function. N Engl J Med 1994; 331:1072-1090.

20.

Li J, Tzu J, Chen Y, Zhang Y, Nguyen N, Gao J, et al. Laminin-10 is crucial for hair morphogenesis. EMBO J 2003; 22:2400-2410.

21.

Heymann W. Thyroid Disorders with Cutaneous Manifestations. 1st ed. 2008.p. 134-156.

22.

Hanley K, Devaskar UP, Hicks S, Jiang Y, Crumrine D, Elias PM, et al. Hypothyroidism delays fetal stratum corneum development in mice. Pediatr Res J 1997; 42:610-614.

23.

Peltonen J, Larjava H, Jaakkola S, Gralnick H, Akiyama SK, Yamada S, et al. Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable xpression in basal and squamous cell carcinomas. J Clin Invest 1988; 84:1916–1923.

24.

Daumerie C, Ludgate M, Costagliola S, Many MC. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol 2002; 146:35-38.

25.

Engfeldt P, Arner P, Bolinder A, Wennlund A, Ostman J. Phosphodiesterase activity in human subcutaneous adipose tissue in hyper- and hypothyroidism. J Clin Endocrinol Metabol 1982; 54:625-629.

26.

Robert M, Herrera E. Effect of postweaning thyroid status on endocrine and adipose development in rats. Am J Phisiol 1988; 255:280-286.

27.

Safer JD, Crawford TM, Fraser LM, Hoa M, Ray S, Chen TC, et al. Thyroid hormone action on skin: diverging effects of topical versus intraperitoneal administration. Thyroid 2003; 13:159-165.

28.

Holt PJ, Marks R. The epidermal response to change in thyroid status. J Invest Dermatol 1977; 68:299-301.

29.

Holt PJ, Lazarus J, Marks R. The epidermis in thyroid disease. Br J Dermatol 1976; 95:513-518.